Maury Raycroft
Stock Analyst at Jefferies
(1.83)
# 3,286
Out of 5,157 analysts
59
Total ratings
35.56%
Success rate
-8.2%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $32 → $43 | $34.74 | +23.78% | 4 | Feb 3, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $66 → $81 | $86.92 | -6.81% | 3 | Feb 2, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $114 → $63 | $22.84 | +175.83% | 1 | Dec 30, 2025 | |
| MREO Mereo BioPharma Group | Downgrades: Hold | $7 → $0.5 | $0.40 | +25.09% | 2 | Dec 30, 2025 | |
| CELC Celcuity | Maintains: Buy | $108 → $134 | $117.10 | +14.43% | 2 | Dec 2, 2025 | |
| AUPH Aurinia Pharmaceuticals | Upgrades: Buy | $10 → $21 | $14.80 | +41.89% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Downgrades: Hold | $2 → $1.6 | $1.19 | +34.45% | 1 | Oct 31, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $550 → $549 | $322.38 | +70.30% | 4 | Oct 30, 2025 | |
| KZR Kezar Life Sciences | Downgrades: Hold | $18 → $7 | $7.13 | -1.82% | 2 | Oct 17, 2025 | |
| KOD Kodiak Sciences | Initiates: Buy | $15 | $25.11 | -40.26% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $3.5 | $2.02 | +73.27% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $53 | $10.04 | +427.89% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $5.57 | +43.63% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.41 | +624.81% | 1 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $15.58 | -61.49% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $16.50 | +15.15% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $15 | $4.05 | +270.37% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.31 | +1,835.48% | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $1.76 | +1,206.82% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $195 | $2.40 | +8,025.00% | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $8.75 | +25.71% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $6 | $40.25 | -85.09% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $75 | $59.20 | +26.69% | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.21 | +242.68% | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $38 → $5 | $1.47 | +240.14% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $11.33 | +217.74% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $105 | $8.18 | +1,183.62% | 1 | May 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $172 | $52.80 | +225.76% | 2 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.27 | +1,970.48% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $13.47 | +211.80% | 3 | Nov 1, 2017 |
Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $34.74
Upside: +23.78%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66 → $81
Current: $86.92
Upside: -6.81%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114 → $63
Current: $22.84
Upside: +175.83%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7 → $0.5
Current: $0.40
Upside: +25.09%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108 → $134
Current: $117.10
Upside: +14.43%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10 → $21
Current: $14.80
Upside: +41.89%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2 → $1.6
Current: $1.19
Upside: +34.45%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550 → $549
Current: $322.38
Upside: +70.30%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18 → $7
Current: $7.13
Upside: -1.82%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $25.11
Upside: -40.26%
Jun 24, 2025
Initiates: Hold
Price Target: $3.5
Current: $2.02
Upside: +73.27%
Mar 11, 2025
Maintains: Buy
Price Target: $70 → $53
Current: $10.04
Upside: +427.89%
Feb 10, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $5.57
Upside: +43.63%
Dec 31, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.41
Upside: +624.81%
Nov 18, 2024
Initiates: Buy
Price Target: $6
Current: $15.58
Upside: -61.49%
Jul 17, 2024
Initiates: Buy
Price Target: $19
Current: $16.50
Upside: +15.15%
May 7, 2024
Assumes: Buy
Price Target: $23 → $15
Current: $4.05
Upside: +270.37%
Mar 13, 2024
Initiates: Buy
Price Target: $6
Current: $0.31
Upside: +1,835.48%
Mar 5, 2024
Initiates: Buy
Price Target: $23
Current: $1.76
Upside: +1,206.82%
Feb 8, 2024
Initiates: Buy
Price Target: $195
Current: $2.40
Upside: +8,025.00%
Aug 4, 2023
Upgrades: Buy
Price Target: $11
Current: $8.75
Upside: +25.71%
Jan 4, 2023
Downgrades: Hold
Price Target: $32 → $6
Current: $40.25
Upside: -85.09%
Nov 29, 2022
Maintains: Buy
Price Target: $92 → $75
Current: $59.20
Upside: +26.69%
Sep 12, 2022
Initiates: Buy
Price Target: $11
Current: $3.21
Upside: +242.68%
Dec 2, 2021
Downgrades: Hold
Price Target: $38 → $5
Current: $1.47
Upside: +240.14%
Jun 1, 2021
Initiates: Buy
Price Target: $36
Current: $11.33
Upside: +217.74%
May 27, 2021
Initiates: Buy
Price Target: $105
Current: $8.18
Upside: +1,183.62%
Apr 21, 2021
Upgrades: Buy
Price Target: $172
Current: $52.80
Upside: +225.76%
Feb 24, 2020
Initiates: Buy
Price Target: $47
Current: $2.27
Upside: +1,970.48%
Nov 1, 2017
Maintains: Buy
Price Target: $36 → $42
Current: $13.47
Upside: +211.80%